These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 843724)

  • 21. Inhibitory effects of GABA, L-glutamic acid and nicotine on the potassium-evoked release of substance P in substantia nigra slices of the rat.
    Torrens Y; Beaujouan JC; Besson MJ; Michelot R; Glowinski J
    Eur J Pharmacol; 1981 May; 71(4):383-92. PubMed ID: 6166487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceedings: Pharmacological studies on single neurones in the substantia nigra of the rat.
    Crossman AR; Walker RJ; Woodruff GN
    Br J Pharmacol; 1974 May; 51(1):137P-138P. PubMed ID: 4155331
    [No Abstract]   [Full Text] [Related]  

  • 23. Distinct mechanisms of presynaptic inhibition at GABAergic synapses of the rat substantia nigra pars compacta.
    Giustizieri M; Bernardi G; Mercuri NB; Berretta N
    J Neurophysiol; 2005 Sep; 94(3):1992-2003. PubMed ID: 15944237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some neuroactive compounds in the substantia nigra.
    Krnjević K
    Adv Neurol; 1974; 5():145-52. PubMed ID: 4155230
    [No Abstract]   [Full Text] [Related]  

  • 25. L-DOPA-induced modulation of GABA and glutamate release in substantia nigra pars reticulata in a rodent model of Parkinson's disease.
    Ochi M; Shiozaki S; Kase H
    Synapse; 2004 May; 52(2):163-5. PubMed ID: 15034922
    [No Abstract]   [Full Text] [Related]  

  • 26. D-tubocurarine reduces GABA responses in rat substantia nigra dopamine neurons.
    Caputi L; Bengtson CP; Guatteo E; Bernardi G; Mercuri NB
    Synapse; 2003 Mar; 47(3):236-9. PubMed ID: 12494406
    [No Abstract]   [Full Text] [Related]  

  • 27. Direct demonstration of interactions between substance P immunoreactive terminals and tyrosine hydroxylase immunoreactive neurons in the substantia nigra of the rat: an ultrastructural study.
    Mahalik TJ
    Synapse; 1988; 2(5):508-15. PubMed ID: 2460962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proceedings: The actions of GABA on d.c. and field potential recordings from the rat cuneate nucleus.
    Hill RG; Hornby J; Roberts F
    Br J Pharmacol; 1975 Oct; 55(2):280P. PubMed ID: 1201415
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of gamma-aminobutyric acid on the potassium and tyramine induced release of [3Hi1-noradrenaline from rat occipital cortex slices [proceedings].
    Arbilla S; Langer SZ
    Br J Pharmacol; 1978 Jun; 63(2):389P-390P. PubMed ID: 667464
    [No Abstract]   [Full Text] [Related]  

  • 30. Microelectrophoretic effects of (+/-) cis-1,3-aminocyclohexane carboxylic acid on nigral neurones in control and tetanus toxin treated rats [proceedings].
    Davies J; Tongroach P
    Br J Pharmacol; 1978 Mar; 62(3):430P. PubMed ID: 638354
    [No Abstract]   [Full Text] [Related]  

  • 31. Depolarizing actions of gamma-aminobutyric acid (GABA) on mammalian brain slices [proceedings].
    Galvan M; Scholfield CN; Brown DA
    Br J Pharmacol; 1978 Mar; 62(3):410P. PubMed ID: 638340
    [No Abstract]   [Full Text] [Related]  

  • 32. The GABA-mimetic action of etomidate [proceedings].
    Evans RH; Hill RG
    Br J Pharmacol; 1977 Nov; 61(3):484P. PubMed ID: 588833
    [No Abstract]   [Full Text] [Related]  

  • 33. Substance P in the substantia nigra.
    Davies J; Dray A
    Brain Res; 1976 May; 107(3):623-7. PubMed ID: 1268746
    [No Abstract]   [Full Text] [Related]  

  • 34. Developmental profiles of substance P and GABA contents in the substantia nigra of rat.
    Kanazawa I; Tatsumi S; Nagano H; Muramoto O
    Neurosci Lett; 1982 Dec; 34(2):149-52. PubMed ID: 6191252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proceedings: Interaction between GABA and butyrophenones in cerebellar purkinje cells in cats.
    Maruyama S; Kawasaki T
    Nihon Seirigaku Zasshi; 1974 Sep; 36(8-9):270. PubMed ID: 4157022
    [No Abstract]   [Full Text] [Related]  

  • 36. The action of substance P on mesencephalic reticular and substantia nigral neurones of the rat.
    Walker RJ; Kemp JA; Yajima H; Kitagawa K; Woodruff GN
    Experientia; 1976 Feb; 32(2):214-5. PubMed ID: 1269616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proceedings: Distribution of choline, GABA and adrenaline reactive neural control in the preoptic area].
    Kataoka K; Tanmachi M; Okuno S; Mizuno N
    Nihon Seirigaku Zasshi; 1974 Sep; 36(8-9):278. PubMed ID: 4157023
    [No Abstract]   [Full Text] [Related]  

  • 38. Substance P content of substantia nigra after chronic treatment with antischizophrenic drugs.
    Hong JS; Yang HT; Costa E
    Neuropharmacology; 1978 Jan; 17(1):83-5. PubMed ID: 26031
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of substance P and SP(1-7) on dopamine release from rat substantia nigra.
    Hall ME; Nockels C; Stewart JM
    Ann N Y Acad Sci; 1991; 632():407-9. PubMed ID: 1719889
    [No Abstract]   [Full Text] [Related]  

  • 40. Asymmetric increase in substance P immunoreactivity in the rat and guinea pig substantia nigra after unilateral neocortical ablation.
    Bouras C; Vallet PG; Hof PR
    Neurosci Lett; 1991 Nov; 133(1):53-6. PubMed ID: 1724312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.